PRVBProvention Bio, Inc.

Nasdaq proventionbio.com


$ 25.00 $ 0.75 (3.1 %)    

Wednesday, 26-Apr-2023 15:59:56 EDT
QQQ $ 439.55 $ -0.26 (-0.06 %)
DIA $ 390.50 $ 1.74 (0.45 %)
SPY $ 517.10 $ 0.05 (0.01 %)
TLT $ 90.18 $ -0.55 (-0.61 %)
GLD $ 213.58 $ -0.63 (-0.29 %)
$ 24.98
$ 24.97
$ -214,748.36 x 0
$ 0.00 x 0
$ 24.97 - $ 25.00
$ 3.19 - $ 25.00
9,124,151
na
2.37B
$ 1.66
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-29-2023 12-31-2022 10-K
2 11-03-2022 09-30-2022 10-Q
3 08-04-2022 06-30-2022 10-Q
4 05-05-2022 03-31-2022 10-Q
5 02-24-2022 12-31-2021 10-K
6 11-04-2021 09-30-2021 10-Q
7 08-05-2021 06-30-2021 10-Q
8 05-06-2021 03-31-2021 10-Q
9 02-25-2021 12-31-2020 10-K
10 11-05-2020 09-30-2020 10-Q
11 08-06-2020 06-30-2020 10-Q
12 05-07-2020 03-31-2020 10-Q
13 03-12-2020 12-31-2019 10-K
14 11-05-2019 09-30-2019 10-Q
15 08-06-2019 06-30-2019 10-Q
16 05-08-2019 03-31-2019 10-Q
17 03-19-2019 12-31-2018 10-K
18 11-08-2018 09-30-2018 10-Q
19 08-13-2018 06-30-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Sanofi announced today that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the...

Core News & Articles

Sanofi announced today that it has withdrawn and refiled its Premerger Notification and Report Form under the Hart-Scott-Rodino...

 top-5-health-care-stocks-that-may-crash-in-march

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

 earnings-scheduled-for-march-16-2023

Companies Reporting Before The Bell • KVH Industries (NASDAQ:KVHI) is projected to report quarterly earnings at $0.03 per shar...

 provention-bios-earnings-outlook
Provention Bio's Earnings Outlook
03/15/2023 18:01:55

 hc-wainwright--co-downgrades-provention-bio-to-neutral-raises-price-target-to-25

HC Wainwright & Co. analyst Raghuram Selvaraju downgrades Provention Bio (NASDAQ:PRVB) from Buy to Neutral and raises th...

 top-5-health-care-stocks-that-are-ticking-portfolio-bombs

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

 smbc-nikko-downgrades-provention-bio-to-neutral-raises-price-target-to-25

SMBC Nikko analyst David Hoang downgrades Provention Bio (NASDAQ:PRVB) from Outperform to Neutral and raises the price targe...

 jefferies-downgrades-provention-bio-to-hold-announces-25-price-target

Jefferies analyst Chris Howerton downgrades Provention Bio (NASDAQ:PRVB) from Buy to Hold and announces $25 price target.

 nasdaq-up-150-points-gold-rises-over-2

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 150 points on Monday. The Dow tr...

 why-bank-shares-are-trading-lower-here-are-other-stocks-moving-in-mondays-mid-day-session

Gainers Provention Bio, Inc. (NASDAQ: PRVB) shares jumped 250.8% to $23.50 after Sanofi announced it will acquire the compa...

 dow-jumps-300-points-crude-oil-down-1

U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 300 points on Monday. The Dow traded up 0....

 illumina-seagen-and-other-big-stocks-moving-higher-on-monday

U.S. stocks traded slightly lower, with the Nasdaq Composite dropping around 0.2% on Monday. Here are some big stocks recording...

 us-stocks-mostly-higher-dow-rises-75-points

U.S. stocks traded mostly higher this morning, with the Dow Jones gaining around 75 points on Monday. Following the market ope...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION